FDA Posting Quarterly Reports of Potential Drug Safety Issues-September 2008

Article

The FDA's new system for quarterly reporting of potential drug safety issues to the public is now available

The first quarterly report by the FDA of drugs that are being evaluated for potential safety issues has been posted to the FDA’s Web site. The list of drugs—identified based on a review of reports in the FDA’s Adverse Event Reporting System (AERS)—is required by Congress as part of FDA amendments signed into law last year.

The agency stresses that the appearance of a drug on this list does not mean that the FDA has concluded the drug has the listed risk, or that the FDA has identified a causal relationship between the drug and the listed risk.

“My message to patients is this: Don’t stop taking your medicine. If your doctor has prescribed a drug that appears on this list, you should continue taking it, unless your doctor advises you differently,” said Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research.

If a drug appears on the AERS-based quarterly report, it means that the FDA has begun an analysis to determine whether there is a safety problem. Depending on the level of analysis completed, it may be too early to know whether there is a safety problem, and the FDA’s analysis may ultimately conclude there is no safety problem, the FDA notes.

The quarterly reports will not be cumulative; they will list only drugs for which new safety information or potential signals of serious risk have been identified through AERS during the previous 3 months.

More information on the report, “Potential Signals of Serious Risks Identified by AERS,” as well as a listing of the 20 drugs identified for the period January-March 2008, can be found at

www.fda.gov/cder/aers

.

Related Videos
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Pharmacist holding medicine box and capsule pack in pharmacy drugstore. -- Image credit: I Viewfinder | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.